122 related articles for article (PubMed ID: 19474756)
1. Prevalence of cervical cancer screening of HIV-infected women in the United States.
Oster AM; Sullivan PS; Blair JM
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):430-6. PubMed ID: 19474756
[TBL] [Abstract][Full Text] [Related]
2. Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.
Frazier EL; Sutton MY; Tie Y; McNaghten AD; Blair JM; Skarbinski J
J Womens Health (Larchmt); 2016 Feb; 25(2):124-32. PubMed ID: 26447835
[TBL] [Abstract][Full Text] [Related]
3. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
[TBL] [Abstract][Full Text] [Related]
4. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
6. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
7. Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.
Setse R; Siberry GK; Moss WJ; Gravitt P; Wheeling T; Bohannon B; Dominguez K;
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):27-34. PubMed ID: 22088311
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of cervical squamous cell abnormalities among HIV-infected women with immunological AIDS-defining illnesses.
Chalermchockcharoenkit A; Sirimai K; Chaisilwattana P
J Obstet Gynaecol Res; 2006 Jun; 32(3):324-9. PubMed ID: 16764624
[TBL] [Abstract][Full Text] [Related]
9. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer in HIV-infected women receiving care in the United States.
Stein MD; Cunningham WE; Nakazono T; Turner BJ; Andersen RM; Bozzette SA; Shapiro MF;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):463-6. PubMed ID: 11511823
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of cervical cancer screening among injection drug users.
McKnight B; McKnight I; Kerr T; Li K; Montaner J; Wood E
J Obstet Gynaecol Can; 2006 Aug; 28(8):695-699. PubMed ID: 17022909
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
13. Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor.
Davies O; Rajamanoharan S; Balachandran T
Int J STD AIDS; 2015 Nov; 26(13):945-50. PubMed ID: 25505037
[TBL] [Abstract][Full Text] [Related]
14. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for nonadherence with Pap testing in HIV-infected women.
Baranoski AS; Horsburgh CR; Cupples LA; Aschengrau A; Stier EA
J Womens Health (Larchmt); 2011 Nov; 20(11):1635-43. PubMed ID: 21879883
[TBL] [Abstract][Full Text] [Related]
17. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
18. Cervical dysplasia on cervicovaginal Papanicolaou smear among HIV-1-infected pregnant and nonpregnant women. Women and Infants Transmission Study.
Stratton P; Gupta P; Riester K; Fox H; Zorrilla C; Tuomala R; Eriksen N; Vajaranant M; Minkoff H; Fowler MG
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):300-7. PubMed ID: 10077181
[TBL] [Abstract][Full Text] [Related]
19. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
20. Patient-provider communication with HIV-positive women about abnormal Pap test results.
Wigfall LT; Bynum SA; Friedman DB; Brandt HM; Richter DL; Glover SH; Hébert JR
Women Health; 2017 Jan; 57(1):19-39. PubMed ID: 26886433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
